DICER1 and sarcoma: One large case series consisted of 22 intracranial sarcomas of which 21 (95%) had DICER1 hotspot mutations as well as TP53 mutations in 50% of cases; germline testing was only performed on five cases of which two had a germline DICER1 mutation183.